Laboratoire M2 manfactures innovative disinfection products from its proprietary platform named THYMOX TECHNOLOGY.
Laboratoire M2 manufactures innovative disinfection products from its proprietary platform named THYMOX TECHNOLOGY. Laboratoire M2 is also working on expanding its line of THYMOX TECHNOLOGY products and applications.the lab which has developed this technology branded as THYMOX.In order to ensure its exclusive ownership of the technology, Laboratoire M2 acquired the intellectual property rights to Thymox. The company holds Canadian and US and South-American patents on the product’s formulation and application, and has applied for patents in 40 other countries.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 8, 2017 | Series B | $4.60M | 1 | Desjardins-Innovatech | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Desjardins-Innovatech | Yes | Series B |